ISB News

Melding ISB and FHCRC Brain Power for Cancer Research

ISB's Ilya Shmulevich describes his lab's work in The Cancer Genome Atlas project and how ISB and FHCRC could collaborate.

(Photo above: ISB’s Dr. Ilya Shmulevich describes his lab’s work in The Cancer Genome Atlas project and how ISB and FHCRC could collaborate.)

Big health challenges require big science. Cancers are prime examples of overwhelmingly complex diseases that need the power of a cross-disciplinary, systems biology approach to decipher the underlying dysfunctional gene networks in order to find ways to prevent and manage the diseases and develop more effective therapies.

ISB's Dr. Nathan Price, left, chats with FHCRC's Dr. David Hockenbery and Dr. Eric Holland during a meeting held at Institute for Systems Biology to discuss potential collaborations on cancer research.

ISB’s Dr. Nathan Price, left, chats with FHCRC’s Dr. David Hockenbery and Dr. Eric Holland during a meeting held at Institute for Systems Biology to discuss potential collaborations on cancer research.

On May 6 at Institute for Systems Biology, researchers from ISB and Fred Hutchinson Cancer Research Center – specifically the Human Biology Division – gathered for a meeting of great minds to identify potential areas for collaboration. It was an intimate showcase for commingling ISB’s pioneering systems approach with the depth of cancer biology knowledge from FHCRC.

 

“We are laying the foundation for a strategic partnership that combines the best of both institutions to attack cancers with systems biology.”

Dr. Nitin Baliga, Senior Vice President and Director of ISB, and project coordinator Dr. Julie Bletz, worked with Dr. Eric Holland, Senior Vice President and Director of the Human Biology Division at FHCRC, to organize the day-long meeting. After introductions, 15 ISB and FHCRC researchers alternated to present their areas of expertise, research challenges, what strengths his/her group could bring to the table and what complementary collaboration the group seeks. The 15 rapid-fire presentations consisted of 15-minute research summaries plus 5 minutes for questions and answers.

The day concluded with group discussions on three topics: potential partnerships and funding opportunities that can be pursued at the investigator level; types of resources both institutions can share and invest in jointly; one or two big problems that both organizations can attack collectively.

“It was a great day, with lots of interesting discussions and potential for collaboration,” said Baliga. “We are laying the foundation for a strategic partnership that combines the best of both institutions to attack cancers with systems biology.”

Recent Articles

  • Dr. Sean Gibbons Promoted to Associate Professor

    Dr. Sean Gibbons – an expert in microbial ecology and evolution, computational systems biology, the human gut microbiome and its impacts on health, and head of ISB’s Gibbons Lab – has been promoted to Associate Professor. “Sean’s achievements since joining ISB in 2018 as a Washington Research Foundation Distinguished Investigator have been spectacular,” ISB President Dr. Jim Heath said. “With his focus on the microbiome, he brought a whole new…

  • AmeriCorps Member Sara Calder Joins ISB as Systems Health and STEM Coordinator

    Sara Calder recently joined ISB as Systems Health and STEM Coordinator, and is our second-ever AmeriCorps member. In this Q&A, Calder shares her education journey, her future plans, and much more.

  • In First-of-Its-Kind Trial, Scientists Use CRISPR to Treat Cancer

    Scientists for the first time have used CRISPR to substitute a gene to treat patients with cancer. The remarkable findings were published in the journal Nature and presented at the Society for Immunotherapy of Cancer (SITC) 2022.